Stock Events

Stock Events

Mineralys Therapeutics (MLYS) Q1 2025 Earnings

12FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.13

-0.98

-0.82

-0.67

Details

Expected EPS

-1.077143

Actual EPS

-0.98

Surprise EPS

0.1

Surprise Percent

+9.02%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -0.98 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.